Novo Nordisk Spends DKK 5.58B on Shares Under DKK 15B Buyback
NVO•Novo Nordisk has repurchased 20,959,179 B shares at an average of DKK 266.09 per share, spending DKK 5.58 billion as of 19 June under its DKK 15 billion buyback programme. The company now holds 38,144,480 B shares in treasury, representing 0.9% of its share capital.
1. Progress on Share Repurchase Programme
As of 19 June, Novo Nordisk has bought back 20,959,179 B shares at an average price of DKK 266.09 per share, allocating DKK 5.577 billion of its DKK 15 billion programme launched on 6 May 2026. This equates to roughly 37% of the total allocated amount, reflecting steady execution.
2. Treasury Share Position
The company currently holds 38,144,480 B shares as treasury stock, representing 0.9% of its share capital. These shares can be reissued for employee incentives, acquisitions or cancelled to enhance shareholder value.
3. Implications for Investors
Ongoing repurchases reduce the share count, which should bolster earnings per share over time. The pace and scale of continued buybacks will signal management’s confidence in valuation and allocation priorities.
